William Farnaby

Title: The Innovations of William Farnaby

Introduction

William Farnaby is a notable inventor based in Fife, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical use. His work focuses on addressing oncological diseases through advanced scientific methods.

Latest Patents

Farnaby holds a patent for a groundbreaking invention titled "Proteolysis targeting chimera (PROTACS) as degraders of SMARCA2 and/or SMARCA4." This patent encompasses compounds of a specific formula, which are designed to act as degraders of SMARCA2 and/or SMARCA4. The invention includes pharmaceutical compositions containing these compounds and their applications as medicaments, particularly for the treatment and prevention of oncological diseases. He has 1 patent to his name.

Career Highlights

William Farnaby is associated with Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role in the company has allowed him to contribute to significant advancements in drug development and therapeutic solutions.

Collaborations

Farnaby has collaborated with esteemed colleagues, including Alessio Ciulli and Christian Dank. These partnerships have fostered a collaborative environment that enhances innovation and research in the pharmaceutical sector.

Conclusion

William Farnaby's contributions to the field of pharmaceuticals through his innovative patent demonstrate his commitment to advancing medical science. His work continues to impact the treatment of oncological diseases, showcasing the importance of innovation in healthcare.